Latest filing published 08 May 2020 for OncBioMune Pharmaceuticals, Inc, €16k.
Insider track record
No signal scores available.
Andrew Albert Kucharchuk: trading record in brief
Andrew Albert Kucharchuk is a declared insider of OncBioMune Pharmaceuticals, Inc, with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 2 September 2015 and the latest from 7 May 2020.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 8 May 2020, reports a share grant of €16k in OncBioMune Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew Albert Kucharchuk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 283,334 shares@ US$0.06100.0% of flowShares of Common StockSEC:0001493152-20-008105:0
- 5,000,000 sharesCommon stockSEC:0001493152-16-007162:0
2 of 2 declarations